The present invention relates to micronisable salmeterol xinafoate polymorph I characterized by a mean particle size of between 5 and 15 µm and a bulk density between 0.1 and 0.2 g/mL, to a method for its preparation and to its use in the preparation of micronised salmeterol xinafoate.